Your browser doesn't support javascript.
loading
Neurological Short-Term Outcomes of a Cohort of Children Born to Zika Virus-Infected Mothers in Barcelona.
Romaní, Natàlia; Pieras, Maria; Frick, Marie Antoinette; Sulleiro, Elena; Rodó, Carlota; Silgado, Aroa; Suy, Anna; Espiau, Maria; Thorne, Claire; Giaquinto, Carlo; Felipe-Rucián, Ana; Soler-Palacín, Pere; Soriano-Arandes, Antoni.
Afiliação
  • Romaní N; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Pieras M; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Frick MA; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Sulleiro E; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Department of Microbiology, Instituto de Salud Carlos III, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
  • Rodó C; Maternal Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
  • Silgado A; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas, Department of Microbiology, Instituto de Salud Carlos III, Hospital Universitari Vall d'Hebron, 08035 Barcelona, Spain.
  • Suy A; Maternal Fetal Medicine Unit, Department of Obstetrics, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
  • Espiau M; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Thorne C; Population, Policy and Practice Research and Teaching Department, Great Ormond Street Institute of Child Health, University College London, London WC1N 1EH, UK.
  • Giaquinto C; Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University-Hospital of Padua, Via Giustiniani 3, 35128 Padua, Italy.
  • Felipe-Rucián A; Pediatric Neurology Section, Pediatric Neurology Research Group, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Soler-Palacín P; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
  • Soriano-Arandes A; Pediatric Infectious Diseases and Immunodeficiencies Unit, Vall d'Hebron Research Institute, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.
Children (Basel) ; 9(10)2022 Oct 09.
Article em En | MEDLINE | ID: mdl-36291474
ABSTRACT
Zika virus (ZIKV) is a vector-borne flavivirus with a known teratogenic effect, yet the full spectrum has not been delineated. Studies on endemic areas tried to characterize the clinical outcomes of ZIKV intrauterine exposure. We aimed to describe early neurodevelopmental outcomes on prenatally ZIKV-exposed children in a non-endemic ZIKV area. This is a prospective observational cohort study conducted from May 2016 to December 2021 at Hospital Universitari Vall d'Hebron in Barcelona, Catalonia, Spain. We monitored for up to 24 months 152 children extracted from a pregnant women cohort with suspected ZIKV infection; eleven women (11/150; 7.3%) fulfilled the criteria for a confirmed ZIKV infection. Among the 152 children included, we describe two cases of congenital ZIKV syndrome (CZS) born from women with a confirmed ZIKV infection. Additionally, we describe five cases of other potentially ZIKV-related outcomes (OPZROs), all with normal birth cranial circumference and born to women with probable ZIKV infection. The low exposed prevalence of adverse outcomes in asymptomatic children at birth in a non-endemic area suggests that close follow-up should be addressed by primary care pediatricians instead of pediatric specialists. Further studies are needed to assess the effects of ZIKV intrauterine exposure beyond two years of life.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Children (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Children (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha